Clinical Trials Browser

Phase 2 × Lisinopril × Clear all

NCT04550481 2026-01-21

Role of Lisinopril in Preventing the Progression of Non-Alcoholic Fatty Liver Disease, RELIEF-NAFLD Study

Phase 2 Active not recruiting

Gastrointestinal

Carcinoma, Hepatocellular, Non-alcoholic Fatty Liver Disease

NCT04190433 2023-05-24

Autophagy Activation for the Alleviation of Cardiomyopathy Symptoms After Anthracycline Treatment, ATACAR Trial

Phase 2 Withdrawn

BreastLymphoidOther hematologic neoplasmSarcoma

Breast Neoplasms, Lymphoma, Sarcoma, Hematologic Neoplasms

NCT01009918 2021-03-30

Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab

Phase 2 Completed

468 enrolled 16 charts

Breast Neoplasms, Breast Neoplasms, Male, Cardiotoxicity

NCT01880528 2020-01-02

Lisinopril in Reducing Shortness of Breath Caused by Radiation Therapy in Patients With Lung Cancer

Phase 2 Completed

23 enrolled 9 charts

Carcinoma, Non-Small-Cell Lung, Dyspnea, Small Cell Lung Carcinoma

NCT01234922 2018-08-28

Benazepril Hydrochloride, Lisinopril, Ramipril, or Losartan Potassium in Treating Hypertension in Patients With Solid Tumors

Phase 2 Terminated

6 enrolled 10 charts

Hypertension